[Use of the vasodilator nitrosorbide in the treatment of chronic heart failure]. 1983

V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
January 1983, Kardiologia polska,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
October 1981, Annals of the Academy of Medicine, Singapore,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
September 1978, British heart journal,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
July 1977, British heart journal,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
January 1984, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
November 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
May 1988, Fortschritte der Medizin,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
April 1983, Danish medical bulletin,
V Iu Mareev, and R A Grigor'iants, and N M Lobova, and V G Naumov
June 1986, Klinicheskaia meditsina,
Copied contents to your clipboard!